Axillary ultrasound after neoadjuvant therapy reduces the false-negative rate of sentinel lymph node biopsy in patients with cytologically node-positive breast cancer

[1] Samiei S(2021)Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis JAMA Surg 156 e210891-3663

[2] Simons JM(2007)Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American college of surgeons oncology group trial Z0011 J Clin Oncol 25 3657-2702

[3] Engelen SME(2005)Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National surgical adjuvant breast and bowel project protocol B-27 J Clin Oncol 23 2694-618

[4] Beets-Tan RGH(2013)Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study Lancet Oncol 14 609-1461

[5] Classe JM(2013)Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial JAMA 310 1455-264

[6] Smidt ML(2015)Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study J Clin Oncol 33 258-1078

[7] Lucci A(2016)Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection J Clin Oncol 34 1072-3369

[8] McCall LM(2015)Does a picture make a difference? Ultrasound guidance in the management of the axilla after neoadjuvant chemotherapy J Clin Oncol 33 3367-564

[9] Beitsch PD(2017)Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update J Clin Oncol 35 561-428

[10] Whitworth PW(2020)Neoadjuvant therapy and sentinel lymph node biopsy in HER2-positive breast cancer patients: results from the PEONY trial Breast Cancer Res Treat 180 423-S475

[1] Samiei S(2021)Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis JAMA Surg 156 e210891-3663

[2] Simons JM(2007)Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American college of surgeons oncology group trial Z0011 J Clin Oncol 25 3657-2702

[3] Engelen SME(2005)Sentinel node biopsy after neoadjuvant chemotherapy in breast cancer: results from National surgical adjuvant breast and bowel project protocol B-27 J Clin Oncol 23 2694-618

[4] Beets-Tan RGH(2013)Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study Lancet Oncol 14 609-1461

[5] Classe JM(2013)Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial JAMA 310 1455-264

[6] Smidt ML(2015)Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study J Clin Oncol 33 258-1078

[7] Lucci A(2016)Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection J Clin Oncol 34 1072-3369

[8] McCall LM(2015)Does a picture make a difference? Ultrasound guidance in the management of the axilla after neoadjuvant chemotherapy J Clin Oncol 33 3367-564

[9] Beitsch PD(2017)Sentinel lymph node biopsy for patients with early-stage breast cancer: American society of clinical oncology clinical practice guideline update J Clin Oncol 35 561-428

[10] Whitworth PW(2020)Neoadjuvant therapy and sentinel lymph node biopsy in HER2-positive breast cancer patients: results from the PEONY trial Breast Cancer Res Treat 180 423-S475